✦ LIBER ✦

Vaccine therapies for Non-Hodgkin’s Lymphoma

✍ Scribed by John M. Timmerman

Book ID: 107531758
Publisher: Springer
Year: 2002
Tongue: English
Weight: 511 KB
Volume: 3
Category: Article
ISSN: 1527-2729
DOI: 10.1007/s11864-002-0030-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapy of non-Hodgkin's lymphoma

✍ J. Coffey; D. C. Hodgson; M. K. Gospodarowicz 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 160 KB

Interferon therapy of non-Hodgkin's lymp

Interferon therapy of non-Hodgkin's lymphoma

✍ Kenneth A. Foon; Mark S. Roth; Paul A. Bunn Jr 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB 👁 2 views

In 1981, the National Cancer Institute undertook Phase I1 trials of interferon alfa-2a in patients with non-Hodgkin's lymphoma (including cutaneous T-cell lymphoma [CTCL]) and chronic lymphocytic leukemia (CLL). A dose of 50 X lo6 U/m2, three times per week, was used initially, then adjusted downwar

Therapeutic vaccines for non-Hodgkin B-c

Therapeutic vaccines for non-Hodgkin B-cell lymphoma

✍ Javier Briones 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 689 KB

Radiation therapy for localized low-grad

Radiation therapy for localized low-grade non-Hodgkin's lymphomas

✍ Richard W. Tsang; Mary K. Gospodarowicz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB

The most common low grade B-cell non-Hodgkin's lymphomas are follicular lymphomas, and extranodal marginal zone lymphomas, also known as mucosa-associated lymphoid tissue (MALT) lymphomas. Localized presentations of follicular lymphoma occur in 20-30% of cases, while for MALT lymphomas, stage I-II d

Non-Hodgkin's lymphoma

✍ Timothy C. Greiner; L. Jeffrey Medeiros; Elaine S. Jaffe 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 1012 KB

Non-Hodgkin's lymphoma

✍ Richard T. Hoppe 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 67 KB